According to Towards Healthcare study, the global in vitro diagnostics market size is calculated at USD 85.09 billion in 2025 and is expected to reach around USD 123.45 billion by 2034, growing at a ...

Report Ocean’s recent report provides an accurate and comprehensive research analysis of the “Saudi Arabia In Vitro Diagnostics (IVD) Quality Control Market” with a primary focus on the present and ...

The Asia Pacific in-vitro diagnostics (IVD) market, valued at USD 15.9 billion in 2023, is set to experience robust growth over the next decade, reaching USD 23.9 billion by 2032, according to new ...

Market Valued at US$ 24.85 Billion in 2023; Surging Demand for Precision Diagnostics and Aging Population Drive Steady Growth ...

IVDR-Certified Platform IDs Bacteria in 5 Hours Across EU Hospitals Hours, Not Days: EU Approval Accelerates 5-Hour Pathogen ID for Critical CasesMolecular Fingerprinting: AI-Powered ‘DNA Barcode’ ...

Dublin, March 28, 2025 (GLOBE NEWSWIRE) -- The "In-Vitro Diagnostic Market - North America and Country Analysis: Focus on Product, Test Type, Application, End User, and Country Analysis - Analysis ...

Further, the US with USD 41.8 billion market in 2023, holds majority share in the global In-vitro Diagnostics market and is likely to remain the leading region growing a CAGR of 5.0% within this ...

RFK Jr. should accept the ruling and instruct the agency to immediately halt all efforts to regulate laboratory-developed and ...

Eurofins Scientific (EUFI.PA), a global scientific leader in bioanalytical testing, with a rapidly developing presence in highly specialised and molecular clinical diagnostics testing and in-vitro ...

Dublin, March 28, 2025 (GLOBE NEWSWIRE) -- The "In-Vitro Diagnostic Market - North America and Country Analysis: Focus on Product, Test Type, Application, End User, and Country Analysis - Analysis and ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced the launch of a new laboratory blood test designed to help ...

Tecan Group today announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics ...